Suzanne Schuh, Judy Sweeney, Maggie Rumantir, Allan L Coates, Andrew R Willan, Derek Stephens, Eshetu G Atenafu, Yaron Finkelstein, Graham Thompson, Roger Zemek, Amy C Plint, Jocelyn Gravel, Francine M Ducharme, David W Johnson, Karen Black, Sarah Curtis, Darcy Beer, Terry P Klassen, Darcy Nicksy, Stephen B Freedman
IMPORTANCE: While intravenous magnesium decreases hospitalizations in refractory pediatric acute asthma, it is variably used because of invasiveness and safety concerns. The benefit of nebulized magnesium to prevent hospitalization is unknown. OBJECTIVE: To evaluate the effectiveness of nebulized magnesium in children with acute asthma remaining in moderate or severe respiratory distress after initial therapy. DESIGN, SETTING, AND PARTICIPANTS: A randomized double-blind parallel-group clinical trial from September 26, 2011, to November 19, 2019, in 7 tertiary-care pediatric emergency departments in Canada...
November 24, 2020: JAMA